{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:41:01Z","timestamp":1792521661271,"version":"4.5.0"},"reference-count":25,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","award":["609767"],"award-info":[{"award-number":["609767"]}],"id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000221","name":"Canadian Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2022,8,23]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Life expectancy for people with cystic fibrosis (CF) varies considerably both within and between countries. The objective of this study was to compare survival among countries with single-payer healthcare systems while accounting for markers of disease severity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cohort study used data from established national CF registries in Australia, Canada, France and New Zealand from 2015 to 2019. Median age of survival for each of the four countries was estimated using the Kaplan-Meier method. A Cox proportional hazards model was used to compare risk of death between Canada, France and Australia after adjusting for prognostic factors. Due to low number of deaths, New Zealand was not included in final adjusted models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2015 and 2019, a total of 14\u2009842 people (3537 Australia, 4434 Canada, 6411 France and 460 New Zealand) were included. The median age of survival was highest in France 65.9 years (95%\u2009CI: 59.8 to 76.0) versus 53.3 years (95%\u2009CI: 48.9 to 59.8) for Australia, 55.4 years (95%\u2009CI: 51.3 to 59.2) for Canada and 54.8 years (95%\u2009CI: 40.7 to not available) for New Zealand. After adjusting for individual-level factors, the risk of death was significantly higher in Canada (HR 1.85, 95%\u2009CI: 1.48 to 2.32; p&lt;0.001) and Australia (HR 2.08, 95%\u2009CI: 1.64 to 2.64; p&lt;0.001) versus France.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>We observed significantly higher survival in France compared with countries with single-payer healthcare systems. The median age of survival in France exceeded 60 years of age despite having the highest proportion of underweight patients which may be due to differences in availability of transplant.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2022-219086","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T17:21:25Z","timestamp":1663262485000},"page":"242-248","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand"],"prefix":"10.1136","volume":"78","author":[{"given":"Ad\u00e8le","family":"Coriati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa","family":"Ruseckaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Dehillotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-3172","authenticated-orcid":false,"given":"Catherine Ann","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-7139","authenticated-orcid":false,"given":"Scott C","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"Pierre Regis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"2024051320310036000_78.3.242.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02288-2020"},{"key":"2024051320310036000_78.3.242.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62161-9"},{"key":"2024051320310036000_78.3.242.3","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0858"},{"key":"2024051320310036000_78.3.242.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.08.026"},{"key":"2024051320310036000_78.3.242.5","doi-asserted-by":"crossref","first-page":"297-305","DOI":"10.1016\/j.jcf.2017.11.013","article-title":"Epidemiology of CF: how registries can be used to advance our understanding of the CF population","volume":"17","author":"Jackson","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024051320310036000_78.3.242.6","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90063-7"},{"key":"2024051320310036000_78.3.242.7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2020.12.001","article-title":"Bridging the survival gap in cystic fibrosis: an investigation of lung transplant outcomes in Canada and the United States","volume":"40","author":"Stephenson","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2024051320310036000_78.3.242.8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jclinepi.2014.12.010","article-title":"A statistical model to predict one-year risk of death in patients with cystic fibrosis","volume":"68","author":"Aaron","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"2024051320310036000_78.3.242.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2024051320310036000_78.3.242.10","first-page":"1","article-title":"Cdc growth charts: United States","author":"Kuczmarski","year":"2000","journal-title":"Adv Data"},{"key":"2024051320310036000_78.3.242.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7244.1240"},{"key":"2024051320310036000_78.3.242.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2007.03706.x"},{"key":"2024051320310036000_78.3.242.13","doi-asserted-by":"publisher","DOI":"10.2307\/2291635"},{"key":"2024051320310036000_78.3.242.14","unstructured":"Team RC . R: a language and environment for statistical computing. R foundation for statistical computing, 2012. Available: http:\/\/www.R-project.org\/"},{"key":"2024051320310036000_78.3.242.15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2020.07.017","article-title":"Projecting the impact of delayed access to elexacaftor\/tezacaftor\/ivacaftor for people with cystic fibrosis","volume":"20","author":"Stanojevic","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2024051320310036000_78.3.242.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901073400104"},{"key":"2024051320310036000_78.3.242.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1749"},{"key":"2024051320310036000_78.3.242.18","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu259"},{"key":"2024051320310036000_78.3.242.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00014-2021"},{"key":"2024051320310036000_78.3.242.20","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.113"},{"key":"2024051320310036000_78.3.242.21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/pch\/15.9.590","article-title":"Newborn screening for cystic fibrosis in Alberta: two years of experience","volume":"15","author":"Lilley","year":"2010","journal-title":"Paediatr Child Health"},{"key":"2024051320310036000_78.3.242.22","doi-asserted-by":"publisher","DOI":"10.1136\/fn.80.1.F1"},{"key":"2024051320310036000_78.3.242.23","first-page":"151","article-title":"Experience with neonatal screening for cystic fibrosis in New Zealand using measurement of immunoreactive trypsinogen","volume":"25","author":"Wesley","year":"1989","journal-title":"Aust Paediatr J"},{"key":"2024051320310036000_78.3.242.24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/aje\/kwab179","article-title":"National health spending, health-care resources, service utilization, and health outcomes","volume":"191","author":"Tanaka","year":"2022","journal-title":"Am J Epidemiol"},{"key":"2024051320310036000_78.3.242.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.265"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:46:59Z","timestamp":1715658419000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,16]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/thorax-2022-219086"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219086","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]}}}